Thank you for visiting Hönle Investor Relations!
Dr. Hönle AG is among the leading companies in the field of UV technology worldwide. The innovative UV radiation systems facilitate the optimization of manufacturing methods across various industries. The company is a pace setter in UV technology and in the development of new applications.
With the information on the investor relations pages we want to give you an overview of the current economic situation of our company. Here, you can find information about our stock, company structure, facts and figures, as well as our financial calendar.
Prof. Dr. Karl Hönle (Chairman)
Professor Hönle is one of the founders of Dr. Hönle Aktiengesellschaft and has been a member of the company's Supervisory Board since 1999. He is Professor Emeritus at Munich University, held the chair for Technical Optics and Laser Technology and was an authorized representative for the technology transfer and trade fair participation of Bavarian applied sciences universities. As member of the Panel, Professor Hönle heads the "Labor für Lichttechnik" (GbR) and is a member of the Authorized Standardization Committee for Light Technology at the German Institute for Standardization [DIN, Deutsches Institut für Normung]. In addition, Professor Hönle is Chief Executive Officer of Dr. Hönle Medizintechnik GmbH.
Günther Henrich (Co-Chairman)
Mr. Henrich is Advisory Board Chairman of Pfeifer Holding GmbH & Co. KG, Memmingen. Following his activities at the Ministry of Economic Affairs in Bavaria, and at LfA Förderbank Bavaria, Mr. Henrich held the position of Chief Executive Officer of BayBG Bayerische Beteiligungsgesellschaft mbH and its predecessor companies from 1987 to 2012. Mr. Henrich contributed significantly to BayBG’s current positioning as market leader for private equity of SMEs in Bavaria. As a consequence, Mr. Henrich has an extensive network in the Bavarian industry. He took on various supervisory and advisory board mandates at small-and medium-sized companies. Moreover, Mr. Henrich was active as Chairman of an expert group and Board member of German Association of Equity Investment Companies [BVK Bundesverband deutscher Kapitalbeteiligungsgesellschaften].
Dr. Bernhard Gimple
Dr. Gimple is active as an attorney in Munch since 2001. After completing his law studies and gaining his doctorate from Ludwig-Maximilian University Munich, Dr. Gimple initially worked for several nationwide law firms before founding, together with a colleague, the SOLEOS law firm in the year 2011. Since November 2005, the trained banker additionally is active as bond trustee for Stadtsparkasse Munich [Pfandbrieftreuhänder der Stadtsparkasse München].
Prof. Dr. Imke Libon
Prof. Dr. Libon is Professor of Physics and Didactics at Munich University of Applied Sciences since 2009 and Dean of the Faculty of Applied Natural Sciences and Mechatronics at Munich University of Applied Sciences since 2019. After completing her physics studies, she did her doctorate in applied optoelectronics at the Ludwig Maximilians University in Munich. Then she worked for six years as a strategic management consultant at Booz Allen Hamilton in interdisciplinary projects in several European countries before she received a call from the Munich University of Applied Sciences. After moving to the Munich University of Applied Sciences, she held various positions and honorary positions for several years in addition to her teaching activities, where she was Vice Dean of the Faculty from 2014 to 2019. Since 2019 she is also Deputy Chairwoman of the Administrative Board of the Munich Student Union [Studentenwerk München].
The articles and analyses published on our web pages are intended only for informational purposes and do not represent offers for the purchase or selling of securities or other investment instruments. The present data are compiled to the best of our knowledge and in good faith. With regard to future-related statements neither Dr. Hönle AG nor any of the associated companies can assume responsibility for the occurrence of the forecast. Due to changing general economic conditions or other factors beyond the control of Dr. Hönle AG, future results may differ considerably from the forecast. Irrespective of legal obligations for adjusting forecasts, Dr. Hönle AG does not intend to continually update all statements related to the future.
Do you need further information about our company or our stock? Do you have any suggestions for our web pages? We would be pleased to receive your request.
Investor Relations Manager
Dr. Hönle AG
Phone: +49 8105 2083 173